Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To provide idelalisib in an open-label format prior to the expected time of regulatory approval to subjects with relapsed CLL who have limited treatment options.
Inclusion criteria
- Chronic lymphocytic leukemia